Morning Market Losers

Rocket Fuel FUEL shares dipped 27.03% to $18.06 after the company reported a Q2 loss of $0.11 per share on revenue of $92.60 million. Rocket Fuel also announced the acquisition of [x+1] for $230 million. Cytori Therapeutics CYTX shares slipped 24.77% to $1.58 after the company reported that it has placed enrollment in the ATHENA and ATHENA II trials on clinical hold. Ascendiant Capital downgraded Cytori Therapeutics from Buy to Hold and removed the price target of $4.00. Lionbridge Technologies LIOX declined 22.09% to $4.55 after the company reported Q2 earnings of $0.12 on revenue of $130.50 million. Nu Skin Enterprises NUS shares dropped 20.74% to $45.91 after the company reported downbeat quarterly results and issued a weak forecast. Globus Medical GMED slipped 19.73% to $18.11 on Q2 results. Sprint S dropped 17.45% to $6.01 after Wall Street Journal reported that Sprint was abandoning its efforts to acquire T-Mobile US TMUS, citing regulatory issues. Sprint named Marcelo Claure as its President and CEO. Groupon GRPN fell 16.47% to $5.91 after the company reported downbeat revenue for the second quarter and issued a weak earnings forecast for the current quarter. Cognizant Technology Solutions CTSH shares declined 15.69% to $42.14 after the company lowered its FY14 revenue growth outlook. The company also reported a rise in its second-quarter profit. Walgreen Co WAG shares dropped 14% to $59.44 following the announcement of Boots acquisition. Walgreen lifted its dividend by 7.1%. Time Warner TWX shares slipped 11.54% to $75.36 after Twenty-First Century Fox FOX announced Tuesday that it is withdrawing its bid for Time Warner TWX. Time Warner reported upbeat second-quarter profit on Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsInformation TechnologyIT Consulting & Other Servicesmarket losersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!